Balance Sheet Data
TG Therapeutics, Inc. (TGTX)
$14.7
-0.21 (-1.41%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 68.81 | 140.43 | 605.43 | 314.76 | 161.68 | 67,608.86 | 1,501,692.04 | 33,354,783.34 | 740,858,672.16 | 16,455,558,007.55 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 0.10 | 0.10 | 0.10 | 4.18 | 1.74 | 38.66 | 858.74 | 19,073.79 | 423,656.81 | 9,410,039.39 |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | - | - | - | - | - | - | - |
| Inventories (%) | ||||||||||
| Accounts Payable | - | - | 37.01 | 1,628.86 | 678.18 | 15,063.46 | 334,581.65 | 7,431,549.36 | 165,065,614.02 | 3,666,349,451.75 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.09 | -0.13 | -0.36 | -0.40 | -2.69 | -59.73 | -1,326.77 | -29,469.62 | -654,563.46 | -14,538,814.84 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.